CorMedix (CRMD) Tops Q4 EPS by 5c
Tweet
Share
E-mailGet Alerts CRMD Hot Sheet
Join SI Premium – FREE
CorMedix (NASDAQ: CRMD) reported Q4 EPS of $0.22, $0.05 better than the analyst estimate of $0.17. Revenue for the quarter came in at $31.2 million versus the consensus estimate of $31 million.
For earnings history and earnings-related data on CorMedix (CRMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fluent (FLNT) Tops Q2 EPS by 4c
- Nkarta, Inc. (NKTX) Misses Q2 EPS by 18c
- Syntec Optics (OPTX) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
